SQSTM1 and Down syndrome: The first AUTAC described was published by Takahashi et al. and it was able to polyubiquitinate K63 on numerous substrates for recognition by the autophagosome receptor SQSTM1/p62, achieving successful protein degradation and mitochondrial turnover in Down syndrome (DS)-derived fibroblasts.